What Is Neurofibromatosis: Causes, Symptoms, Diagnosis, and Treatment Options

Neurofibromatosis is a group of genetic conditions that cause tumors to grow on nerves and can affect your skin, bones, and nervous system. You can have mild signs like light-brown skin patches or freckling, or more complex issues such as multiple benign nerve tumors and neurological or hearing changes, depending on the NF type.

This article What Is Neurofibromatosis will explain how the different types form, what genetic causes underlie them, and what to expect from diagnosis and ongoing care. You’ll find practical information about symptoms to watch for, how clinicians confirm a diagnosis, and the treatment and monitoring options that help manage quality of life.

Types and Causes

You will learn what drives each major form of neurofibromatosis, how the conditions differ, and which genes and tumors are involved. The descriptions below focus on inheritance patterns, typical symptoms, and key clinical risks.

Genetic Origins

Neurofibromatoses are caused by mutations in genes that control cell growth in nerve tissue. Most commonly, mutations occur in the NF1 gene (chromosome 17) or the NF2 gene (chromosome 22); other genes cause schwannomatosis.
These mutations reduce or eliminate tumor-suppressor protein function, which lets Schwann cells or other nerve-supporting cells proliferate and form tumors.

Inheritance is autosomal dominant for NF1 and NF2: if one parent carries a pathogenic variant, you have a 50% chance of inheriting it. Up to half of cases arise from new (de novo) mutations, so you can develop the condition with no family history.
Genetic testing identifies pathogenic variants in most symptomatic people and guides family planning and surveillance.

Neurofibromatosis Type 1

NF1 results from loss-of-function mutations in the NF1 gene, which encodes neurofibromin, a regulator of the RAS signaling pathway. Broken neurofibromin leads to increased cell growth and the development of multiple benign neurofibromas on or under the skin, along peripheral nerves, and sometimes within deeper tissues.
You commonly notice café-au-lait macules (light brown birthmarks), freckling in the armpits or groin, Lisch nodules in the iris, and cutaneous neurofibromas that increase with age.

Complications include plexiform neurofibromas (congenital, often large and disfiguring), scoliosis, learning disabilities, and an elevated risk of malignant peripheral nerve sheath tumors (MPNST).
Clinical management emphasizes regular skin and neurologic exams, MRI surveillance for symptomatic plexiform tumors, pain control, and targeted therapies (for example, MEK inhibitors) when indicated.

Neurofibromatosis Type 2

NF2 stems from pathogenic variants in the NF2 gene, which encodes the protein merlin (schwannomin). Loss of merlin function promotes tumor growth primarily in Schwann cells.
The hallmark is bilateral vestibular schwannomas (acoustic neuromas) that damage hearing and balance. You may also develop meningiomas, spinal schwannomas, and other intracranial or intraspinal tumors.

Hearing loss, tinnitus, and balance problems typically appear in adolescence or early adulthood, though onset can vary.
Management focuses on preserving hearing and neurologic function through regular MRI, audiology monitoring, surgical resection, stereotactic radiosurgery, and, in selected cases, bevacizumab or other targeted treatments.

Schwannomatosis

Schwannomatosis causes multiple schwannomas without the characteristic bilateral vestibular schwannomas seen in NF2. It arises from mutations in SMARCB1, LZTR1, or mosaic NF2 alterations.
You usually present in adulthood with chronic, often severe pain from peripheral nerve schwannomas. Tumor burden and pain can vary widely between individuals.

Schwannomatosis has a lower overall tumor-related cancer risk than NF1, but it can cause significant neurologic dysfunction and pain.
Diagnosis depends on clinical criteria plus genetic testing; management centers on surgical removal of symptomatic schwannomas, multimodal pain control, and rehabilitation to preserve function.

Symptoms, Diagnosis, and Care

You may notice skin changes, lumps, hearing or vision problems, and learning or pain issues. Medical teams use physical exams, imaging, and genetic testing to confirm diagnosis and guide treatment and long-term monitoring.

Common Physical Manifestations

You often first see skin findings: multiple café-au-lait spots (flat light-brown patches) and freckling in the armpits or groin. Small, soft neurofibromas—benign tumors on or under the skin—appear as bumps that can increase in number and size with age.

Tumors can also develop on internal nerves and along the spine, causing localized pain, weakness, or numbness. In NF2, you may experience ringing in the ears, balance problems, or hearing loss from vestibular schwannomas. Head size and learning differences occur in some people with NF1; attention, executive function, and school performance frequently require evaluation and support.

Methods of Diagnosis

Diagnosis combines clinical criteria, imaging, and genetic testing. A clinician will check for established signs such as six or more café-au-lait spots (size thresholds differ for children and adults), two or more neurofibromas, freckling in skin folds, optic pathway glioma, or characteristic bony abnormalities.

MRI is the preferred imaging to evaluate brain, spinal, and inner-ear tumors. Audiology testing documents hearing loss typical of NF2. Genetic testing (sequencing and deletion/duplication analysis of NF1, NF2, or SMARCB1/LZTR1 for schwannomatosis) confirms diagnosis in most cases and helps with family planning. Family history guides targeted testing for relatives.

Possible Complications

Tumor growth can compress nerves, spinal cord, or organs, leading to pain, weakness, gait disturbance, or bowel/bladder dysfunction. Optic pathway tumors may reduce vision, especially in children, and require early monitoring.

Malignant peripheral nerve sheath tumors (rare) present as rapidly growing, painful masses and need urgent evaluation. Hearing loss in NF2 can progress to deafness without intervention. Learning disabilities, social challenges, and chronic pain are common non-tumor complications that affect daily functioning and quality of life.

Management and Support Options

Care focuses on surveillance, symptom control, and treating risky tumors. Surveillance often includes annual physical exams, periodic MRI (brain and spine as indicated), and regular hearing and vision tests tailored to age and type of NF.

Treatment options include surgical removal of symptomatic tumors, targeted therapies (e.g., MEK inhibitors for shrinking some NF1 plexiform neurofibromas), radiation or radiosurgery in select cases, and rehabilitation (physical therapy, occupational therapy). Genetic counseling, educational supports, pain management, and psychological care address learning, family planning, and mental health needs. Joining specialized NF clinics or patient organizations helps you access multidisciplinary teams and clinical trials.